GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a substantial development in how we treat type 2 diabetes . These injectable therapies work by stimulating the body’s inherent GLP-1 process, https://reidlaboratories293237.wikimidpoint.com/user